Publikationen aus den Jahren vor 2000

Functional imaging of the visual cortex with bold-contrast MRI: hyperventilation decreases signal response
Weckesser M, Posse S, Olthoff U, Kemna L, Dager S, Muller-Gartner HW

veröffentlicht in: Magn Reson Med.; 41: 213-6., 1999

Repetitive transcranial magnetic stimulation of the parietal cortex influences motor imagery
Topper R, Foltys H, Mottaghy FM, Boroojerdi B.

veröffentlicht in: Electroencephalogr Clin Neurophysiol Suppl.; 51: 145-50, 1999

Mathematical analysis of lead field expansions
Taylor JG, Ioannides AA, Muller-Gartner HW

veröffentlicht in: IEEE Trans Med Imaging.; 18: 151-63, 1999

Functional anatomy of intrinsic alertness:evidence for a fronto-parietal-thalamic-brainstem network in the right hemisphere
Sturm W, de Simone A, Krause BJ, Specht K, Hesselmann V, Radermacher I, Herzog H, Tellmann L, Muller-Gartner HW, Willmes K.

veröffentlicht in: Neuropsychologia.; 37: 797-805, 1999

Neurophysiological correlates of the recognition of facial expressions of emotion as revealed by magnetoencephalography
Streit M, Ioannides AA, Liu L, Wolwer W, Dammers J, Gross J, Gaebel W, Muller-Gartner HW.

veröffentlicht in: Brain Res Cogn Brain Res.; 7: 481-91., 1999

Influence of acoustic masking noise in fMRI of the auditory cortex during phonetic discrimination
Shah NJ, Jancke L, Grosse-Ruyken ML, Muller-Gartner HW

veröffentlicht in: J Magn Reson Imaging.; 9: 19-25. , 1999

Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia
Schneider F, Weiss U, Kessler C, Muller-Gartner HW, Posse S, Salloum JB, Grodd W, Himmelmann F, Gaebel W, Birbaumer N

veröffentlicht in: Biol Psychiatry.; 45: 863-71. , 1999

Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1- Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non- human primates and calculation of radiation doses of the 90Y-labelled analogue
Rosch F, Herzog H, Stolz B, Brockmann J, Kohle M, Muhlensiepen H, Marbach P, Muller-Gartner HW

veröffentlicht in: Eur J Nucl Med.; 26: 358-66, 1999

Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET
Reinhardt M, Beu M, Vosberg H, Herzog H, Hubinger A, Reinauer H, Muller-Gartner HW

veröffentlicht in: J Nucl Med.; 40: 977-85. , 1999

Neuronal correlates of encoding and retrieval in episodic memory during a paired-word association llearning task: a functional magnetic resonance imaging study
Mottaghy FM, Shah NJ, Krause BJ, Schmidt D, Halsband U, Jancke L, Muller-Gartner HW

veröffentlicht in: Exp Brain Res.; 128: 332-42. , 1999

Facilitation of picture naming after repetitive transcranial magnetic stimulation
Mottaghy FM, Hungs M, Brugmann M, Sparing R, Boroojerdi B, Foltys H, Huber W, Topper R.

veröffentlicht in: Neurology.; 53: 1806-12, 1999

Serotonin 5HT2 receptors in familial depression
Larisch R, Klimke A, Hamacher K al. e.

veröffentlicht in: . J Nucl Med.; 40: S575. , 1999

Motivation effects in a dichotic listening task as evident from functional magnetic resonance imaging in human subjects
Larisch R, Kotter R, Kehren F, Tosch M, Shah NJ, Kalveram KT, Jancke L, Muller-Gartner HW

veröffentlicht in: Neurosci Lett.; 267: 29-32, 1999

Influence of motor activity on striatal dopamine release: A study using iodobenzamide and SPECT. Neuroimage
Larisch R, Schommartz B, Vosberg H, Muller-Gartner HW
.

Left hemisphere activation during processing of morphologically complex word forms in adults
Laine M, Rinne JO, Krause BJ, Teras M, Sipila H.

veröffentlicht in: Neurosci Lett.; 271: 85-8. , 1999

Episodic retrieval activates the precuneun irrespective of the imagery content of word pair associates. A PET study
Krause BJ, Schmidt D, Mottaghy FM, Taylor J, Halsband U, Herzog H, Tellmann L, Muller-Gartner HW

veröffentlicht in: Brain.; 122: 255-63, 1999

Network analysis in episodic encoding and retrieval of word-pair associates: a PET study
Krause BJ, Horwitz B, Taylor JG, Schmidt D, Mottaghy FM, Herzog H, Halsband U, Muller-Gartner H.

veröffentlicht in: Eur J Neurosci.; 11: 3293-301, 1999

Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose
Heicappell R, Muller-Mattheis V, Reinhardt M, Vosberg H, Gerharz CD, Muller-Gartner H, Ackermann R.

veröffentlicht in: Eur Urol.; 36: 582-7., 1999

Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U, Bender HG, Mueller-Gaertner HW.

veröffentlicht in: Eur J Nucl Med.; 26: 226-30. , 1999

Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients
iegler D, Weise F, Langen KJ, Piolot R, Boy C, Hubinger A, Muller-Gartner HW, Gries FA

veröffentlicht in: Eur J Nucl Med.; 25: 150-6, 1998

Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent
Weckesser M, Griessmeier M, Schmidt D, Sonnenberg F, Ziemons K, Kemna L, Holschbach M, Langen K, Muller-Gartner H.

veröffentlicht in: Eur J Nucl Med.; 25: 150-6., 1998

Influence of acetylcholine on binding of 4-[125I]iododexetimide to muscarinic brain receptors
Weckesser M, Fixmann A, Holschbach M, Muller-Gartner HW.

veröffentlicht in: Nucl Med Biol. , 1998

Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy
Weckesser M, Fixmann A, Holschbach M, Muller-Gartner HW.

veröffentlicht in: Nuklearmedizin.; 37: 156-8, 1998

Influence of acetylcholine on binding of 4-[125I]iododexetimide to muscarinic brain receptors
Weckesser M, Fixmann A, Holschbach M, Muller-Gartner HW

veröffentlicht in: Nucl Med Biol.; 25: 777-80., 1998

Diagnosis, radioiodine and radiotherapy of thyroid carcinomas
Vosberg H

veröffentlicht in: Schweiz Rundsch Med Prax.; 87: 376-82., 1998

Extrarolandic origin of spike and myoclonus activity in epilepsia partialis continua: a magnetoencephalographic and positron emission tomography study
Volkmann J, Seitz RJ, Muller-Gartner HW, Witte OW.

veröffentlicht in: J Neuroimaging.; 8: 103-6, 1998

Facilitation of picture naming by focal transcranial magnetic stimulation of Wernicke's area
Topper R, Mottaghy FM, Brugmann M, Noth J, Huber W.

veröffentlicht in: Exp Brain Res.; 121: 371-8. , 1998

A three stage model of awareness: formulation and initial experimental support
Taylor JG, Jancke L, Shah NJ, Nosselt T, Schmitz N, Himmelback M, Kalenscher T, Muller-Gartner HW

veröffentlicht in: Neuroreport.; 9: 1787-92., 1998

Differential amygdala activation in schizophrenia during sadness
Schneider F, Weiss U, Kessler C, Salloum JB, Posse S, Grodd W, Muller-Gartner HW

veröffentlicht in: Schizophr Res. ; 34: 133-42., 1998

Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors
Muller-Mattheis V, Reinhardt M, Gerharz CD, Furst G, Vosberg H, Muller-Gartner HW, Ackermann R.

veröffentlicht in: Urologe A.8; 37: 609-20, 1998

Imaging techniques in the analysis of brain function and behaviour
Muller-Gartner HW

veröffentlicht in: Trends Biotechnol.; 16: 122-30., 1998

Bi-hemispheric study of single trial MEG signals of the human auditory cortex
Liu LC, Ioannides AA, Muller-Gartner HW

veröffentlicht in: Electroencephalogr Clin Neurophysiol.; 106: 64-78., 1998

Antimyosin scintigraphy for diagnosis and follow-up of patients with clinically suspected myocarditis
Lauer B, Kuhl U, Souvatzoglu M, Vosberg H, Schultheiss HP

veröffentlicht in: Z Kardiol.; 87: 691-8., 1998

Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo
Larisch R, Schulte KW, Vosberg H, Ruzicka T, Muller-Gartner HW.

veröffentlicht in: J Nucl Med.; 39: 996-1001, 1998s

Left-right asymmetry of striatal dopamine D2 receptors
Larisch R, Meyer W, Klimke A, Kehren F, Vosberg H, Muller-Gartner HW.

veröffentlicht in: Nucl Med Commun.; 19: 781-7., 1998

Comparison of iodotyrosines and methionine uptake in a rat glioma model
Langen KJ, Clauss RP, Holschbach M, Muhlensiepen H, Kiwit JC, Zilles K, Coenen HH, Muller-Gartner HW

veröffentlicht in: J Nucl Med.; 39: 1596-9, 1998


Clinical value of positron emission tomography in neuromedicine. Position paper on results of an interdisciplinary consensus conference
Kuhl U, Lauer B, Souvatzoglu M, Vosberg H, Schultheiss HP.

veröffentlicht in: Nervenarzt. ; 69: 1045-60. , 1998

[O-15-butanol Pet activation study on the cerebral representation of declarative memory]
Krause BJ, Schmidt D, Mottaghy FM, Halsband U, Tellmann L, Herzog H, Muller-Gartner HW

veröffentlicht in: Nuklearmedizin.; 37: 257-61, 1998

Differential magnetic resonance signal change in human sensorimotor cortex to finger movements of different rate of the dominant and subdominant hand
Jancke L, Peters M, Schlaug G, Posse S, Steinmetz H, Muller-Gartner H.

veröffentlicht in: Brain Res Cogn Brain Res.; 6: 279-84, 1998

Intensity coding of auditory stimuli: an fMRI study
Jancke L, Shah NJ, Posse S, Grosse-Ryuken M, Muller-Gartner HW.

veröffentlicht in: Neuropsychologia.; 36: 875-83., 1998

The influence of stimulus properties, complexity, and contingency on the stability and variability of ongoing and evoked activity in human auditory cortex
Ioannides AA, Taylor JG, Liu LC, Gross J, Muller-Gartner HW.

veröffentlicht in: Neuroimage. 8: 149-62., 1998

Encoding and retrieval in declarative learning: a positron emission tomography study
Halsband U, Krause BJ, Schmidt D, Herzog H, Tellmann L, Muller-Gartner HW.

veröffentlicht in: Brain Res.; 97: 69-78., 1998

Early diagnosis of cardiac involvement in systemic sclerosis by 123I- MIBG neurotransmitter scintigraphy
Gurtner C, Werner RJ, Winten G, Krause BJ, Wendt T, Hor G, Holzmann H.

veröffentlicht in: Nucl Med Commun.; 19: 849-57. , 1998

Magnetic field tomography analysis of continuous speech.
Gross J, Ioannides AA, Dammers J, Maess B, Friederici AD, Muller-Gartner HW.

veröffentlicht in: Brain Topogr.; 10: 273-81., 1998

Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756
Boy C, Klimke A, Holschbach M, Herzog H, Muhlensiepen H, Rota Kops E, Sonnenberg F, Gaebel W, Stocklin G, Markstein R, Muller-Gartner HW

4.5 Tesla magnetic field reduces range of high energy positrons - Potential implications for positron emission tomography
Wirrwar A, Vosberg H, Herzog H, al. e.

veröffentlicht in: IEEE Nucl Sci.; 44: 184-189. , 1997

Effect of partial volume correction on muscarinic cholinergic receptor imaging with single-photon emission tomography in patients with temporal lobe epilepsy
Weckesser M, Hufnagel A, Ziemons K, Griessmeier M, Sonnenberg F, Hacklander T, Langen KJ, Holschbach M, Elger CE, Muller-Gartner H.

veröffentlicht in: Eur J Nucl Med.; 24: 1156-61., 1997

The design of an animal PET: flexible geometry for achieving optimal spatial resolution or high sensitivity
Weber S, Terstegge A, Herzog H, Reinartz R, Reinhart P, Rongen F, Muller-Gartner HW, Halling.

veröffentlicht in: IEEE Trans Med Imaging.; 16: 684-9., 1997

Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
Schmidt D, Langen KJ, Herzog H, Wirths J, Holschbach M, Kiwit JC, Ziemons K, Coenen HH, Muller-Gartner H.

veröffentlicht in: Eur J Nucl Med.; 24: 1162-6., 1997

FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy.
Reinhardt MJ, Muller-Mattheis VG, Gerharz CD, Vosberg HR, Ackermann R, Muller-Gartner HW.

veröffentlicht in: J Nucl Med.; 38: 99-101., 1997

In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: proton echo planar spectroscopic imaging (PEPSI)
Posse S, Dager SR, Richards TL, Yuan C, Ogg R, Artru AA, Muller-Gartner HW, Hayes C.

veröffentlicht in: Magn Reson Med.; 37: 858-65., 1997

Regional dynamic signal changes during controlled hyperventilation assessed with blood oxygen level-dependent functional MR imaging.
Posse S, Olthoff U, Weckesser M, Jancke L, Muller-Gartner HW, Dager SR.

veröffentlicht in: AJNR Am J Neuroradiol.; 18: 1763-70., 1997

Calculation of relative biological effectiveness for proton beams using biological weighting functions
Paganetti H, Olko P, Kobus H, Becker R, Schmitz T, Waligorski MP, Filges D, Muller-Gartner HW.

veröffentlicht in: Int J Radiat Oncol Biol Phys.; 37: 719-29. , 1997

Effect of the haloperidol tetrahydropyridine metabolite 4-(4-hlorophenyl)-1-[4-(4-fluorophenyl)-4 -oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4- iodophenyl)tropane single photon emission computed tomographic study
Oliver DW, Dormehl IC, Van der Schyf CJ, Neumeyer JL, Hugo N, Keeve R, Rossouw NT, Muller-Gartner HW, Castagnoli N, Jr.

veröffentlicht in: Arzneimittelforschung.; 47: 692-9., 1997

Expectation maximization reconstruction of positron emission tomography images using anatomical magnetic resonance information.
Lipinski B, Herzog H, Kops ER, Oberschelp W, Muller-Gartner HW.

veröffentlicht in: IEEE Trans Med Imaging.; 16: 129-36., 1997

Cingulate function in depression
Larish R, Klimke A, Vosberg H, Gaebel W, Mueller-Gaertner HW.
veröffentlicht in: Neuroreport.; 8: i-ii., 1997

In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression
Larisch R, Klimke A, Vosberg H, Loffler S, Gaebel W, Muller-Gartner HW.

veröffentlicht in: Neuroimage.; 5: 251-60. , 1997

3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.
Langen KJ, Ziemons K, Kiwit JC, Herzog H, Kuwert T, Bock WJ, Stocklin G, Feinendegen LE, Muller-Gartner HW.

veröffentlicht in: J Nucl Med.; 38: 517-22., 1997

Evaluation of QT interval length, QT dispersion and myocardial miodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy.
Langen KJ, Ziegler D, Weise F, Piolot R, Boy C, Hubinger A, Gries FA, Muller-Gartner HW.

veröffentlicht in: Clin Sci (Lond).; 93: 325-33. , 1997

Human monoclonal antibody 99mTc-88BV59: detection of colorectal cancer, recurrent or metastatic disease and immunogenicity assessment
Krause BJ, Baum RP, Staib-Sebler E, Lorenz M, Niesen A, Hor G.

veröffentlicht in: Eur J Nucl Med.; 24: 72-5., 1997

Calculation of residence times and radiation doses using the standard PC software Excel
Herzog H, Zilken H, Niederbremer A, Friedrich W, Muller-Gartner HW.

veröffentlicht in: Eur J Nucl Med. 1997; 24: 1514-21.

Markov random field segmentation of brain MR images.
Held K, Kops ER, Krause BJ, Wells WM, 3rd, Kikinis R, Muller-Gartner HW.

veröffentlicht in: IEEE Trans Med Imaging.; 16: 878-86., 1997

Early changes in fluorine-18-FDG uptake during radiotherapy
Hautzel H, Muller-Gartner HW.

veröffentlicht in: J Nucl Med.; 38: 1384-6., 1997

[Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas]
Borner AR, Muller-Gartner HW

veröffentlicht in: Zentralbl Chir.; 122: 274-85., 1997

Isotretinoin in metastatic thyroid cancer
Borner AR, Simon D, Muller-Gartner HW.

veröffentlicht in: Ann Intern Med.; 127: 246., 1997

[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function
Ziegler D, Schadewaldt P, Pour Mirza A, Piolot R, Schommartz B, Reinhardt M, Vosberg H, Brosicke H, Gries FA.

veröffentlicht in: Diabetologia.; 39: 823-30., 1996

Long-term treatment with the tetrahydropyridine analog (HPTP) of haloperidol influences dopamineligand binding in baboon brain. An [123I]iodobenzamide (IBZM) SPECT study
Van der Schyf CJ, Dormehl IC, Oliver DW, Hugo N, Keeve R, Muller-Gartner HW, Pond SM, Castagnoli N, Jr.

veröffentlicht in: Brain Res Mol Brain Res.; 43: 251-8.

Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography
Rosch F, Herzog H, Plag C, Neumaier B, Braun U, Muller-Gartner HW, Stocklin G.

veröffentlicht in: Eur J Nucl Med.; 23: 958-66., 1996

Functional Magnetic Resonance Studies of Brain Activation
Posse S, Muller-Gartner HW, Dager SR.

veröffentlicht in: Semin Clin Neuropsychiatry.; 1: 76-88., 1996

Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial
Leschke M, Schoebel FC, Mecklenbeck W, Stein D, Jax TW, Muller-Gartner HW, Strauer BE.

veröffentlicht in: J Am Coll Cardiol.; 27: 575-84., 1996

Human monoclonal antibody 99mTc-88BV59: detection of colorectal cancer, recurrent or metastatic disease and immunogenicity assessment
Krause BJ, Baum RP, Staib-Sebler E, Lorenz M, Niesen A, ouml, r G.

veröffentlicht in: Eur J Nucl Med.; 24: 72-5. , 1996

The role of bone scintigraphy in the follow-up of osteogenic sarcoma
Korholz D, Wirtz I, Vosberg H, Ruther W, Jurgens H, Gobel U.

veröffentlicht in: Eur J Cancer.; 32A: 461-4., 1996

[Psoriatic osteoarthropathy and bone scintigraphy]
Holzmann H, Krause BJ, Kaltwasser JP, Werner RJ.

veröffentlicht in: Hautarzt.; 47: 427-31., 1996

Quantitation of regional cerebral blood flow with 15O-butanol and positron emission tomography in humans.
Herzog H, Seitz RJ, Tellmann L, Rota Kops E, Julicher F, Schlaug G, Kleinschmidt A, Muller-Gartner HW.

veröffentlicht in: J Cereb Blood Flow Metab.; 16: 645-9., 1996

[Evaluation of the sympathetic nervous system in silent ischemia with 123I-metaiodobenzylguanidine (MIBG)]
Gurtner C, Schacherer C, Krause BJ, Zickmann J, Klepzig H, Jr., Hor G.

veröffentlicht in: Nuklearmedizin.; 35: 105-11., 1996

Task-relevant late positive component in rats: is it related to hippocampal theta rhythm?
Brankack J, Seidenbecher T, Muller-Gartner HW.

veröffentlicht in: Hippocampus.; 6: 475-82., 1996

Simultaneous assessment of bone collagen synthesis and degradation in patients with different malignant tumours. Comparison with the results of 99mTc-methylene bisphosphonate bone scintigraphy
Withold W, Georgescu G, Khakzad H, Vosberg H, Mueller-Gaertner HW, Reinauer H.

veröffentlicht in: Eur J Clin Chem Clin Biochem.; 33: 479-85., 1995

Efficacy of simultaneous determination of bone alkaline phosphatase mass concentration in serum and urinary excretion of pyridinium cross- links for detection of bone metastases
Withold W, Georgescu G, Khakzad H, Vosberg H, Mueller-Gaertner HW, Reinauer H.

veröffentlicht in: Clin Biochem.; 28: 511-9., 1995

Validation of a dual-isotope technique using 123I-MIBG and 201Tl in the assessment of sympathetic reinnervation following heart transplantation: phantom and patient studies.
Krause BJ, Gurtner C, Kranert WT, Maul FD, Baum RP, Hor G.

veröffentlicht in: Nucl Med Commun. 1995; 16: 675-82.

Sympathetic re-innervation after heart transplantation: dual-isotope neurotransmitter scintigraphy, norepinephrine content and histological examination.
Guertner C, Krause BJ, Klepzig H, Jr., Herrmann G, Lelbach S, Vockert EK, Hartmann A, Maul FD, Kranert TW, Mutschler E, et al.

veröffentlicht in: Eur J Nucl Med. 1995; 22: 443-52.

Localization of a pheochromocytoma using I-123 MIBG adrenal scintigraphy
Shirkare S, Kuwert T, Weckesser M, Czech N, Langen KJ, Muller-Gartner HW.

veröffentlicht in: J Postgrad Med.; 40: 85-7., 1994

Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells
Papaspyrou M, Feinendegen LE, Muller-Gartner HW.

veröffentlicht in: Cancer Res.; 54: 6311-4. , 1994

Myocardial perfusion with [11C]methyl triphenyl phosphonium: measurements of the extraction fraction and myocardial uptake
Krause BJ, Szabo Z, Becker LC, Dannals RF, Scheffel U, Seki C, Ravert HT, Dipaola AF, Jr., Wagner HN, Jr.

veröffentlicht in: J Nucl Biol Med. 1994; 38: 521-6.

[Positron emission tomography. Clinical research, diagnostic value, future developments.Deutsche Gesellschaft fur Nuklearmedizin e.V. Study Group PET]
Hundeshagen H, Biersack HJ, Bull U, Felix R, Gunnewig BJ, Heiss WD, Hor G, Jordan K, Knapp WH, Muller-Gartner HW, et al.

veröffentlicht in: Nuklearmedizin.; 33: 145-53. , 1994

harmacokinetics and radiation dose of oxygen-15 labelled butanol in rCBF studies in humans
Herzog H, Seitz RJ, Tellmann L, Schlaug G, Kleinschmidt A, Nebeling B, Stocklin G, Muller-Gartner HW.

veröffentlicht in: P Eur J Nucl Med.; 21: 138-43., 1994

[Sympathetic reinnervation following heart transplantation--a double- tracer study with 123I-MIBG and 201Tl]
Gurtner C, Klepzig H, Jr., Lelbach S, Krause BJ, Hartmann A, Maul FD, Kranert WT, Hor G.

veröffentlicht in: Nuklearmedizin. 1994; 33: 106-12.

Assessment of brain muscarinic acetylcholinergic receptors in living mice using a simple probe, [125I]-4-iododexetimide and [125I]-4- iodolevetimide
Sasaki M, Muller-Gartner HW, Lever JR, Ravert HT, Dannals RF, Guilarte TR, Wagner HN, Jr.

veröffentlicht in: A Neuropharmacology.; 32: 1441-3., 1993

Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I-iododexetimide andsingle-photon emission computed tomography in epilepsy
Muller-Gartner HW, Mayberg HS, Fisher RS, Lesser RP, Wilson AA, Ravert HT, Dannals RF, Wagner HN, Jr., Uematsu S, Frost JJ.

veröffentlicht in: Ann Neurol.; 34: 235-8., 1993

Identification of task-specific RCBF changes in individual subjects - validation and applications for PET
Knorr U, Weder B, Kleinschmidt A, al. e.

veröffentlicht in: J Comput Assist Tomo.; 17: 517-528., 1993

Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects
Muller-Gartner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, Davatzikos C, Frost JJ.

veröffentlicht in: J Cereb Blood Flow Metab.; 12: 571-83., 1992

Imaging muscarinic cholinergic receptors in human brain in vivo with Spect, [123I]4-iododexetimide, and [123I]4-iodolevetimide
Muller-Gartner HW, Wilson AA, Dannals RF, Wagner HN, Jr., Frost JJ.

veröffentlicht in: J Cereb Blood Flow Metab.; 12: 562-70., 1992

Improved positron emission tomography quantification by Fourier-based restoration filtering.
Links JM, Leal JP, Mueller-Gaertner HW, Wagner HN, Jr.

veröffentlicht in: Eur J Nucl Med.; 19: 925-32., 1992

Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma
Mueller-Gaertner HW, Brzac HT, Rehpenning W.

veröffentlicht in: Cancer. ; 67: 1903-11., 1991

Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis.
Schroder S, Bay V, Dumke K, Kremens B, Muller-Gartner HW, Bocker W, Kastendieck H.

veröffentlicht in: Virchows Arch A Pathol Anat Histopathol.; 416: 367-71. , 1990

[TSH receptors in autonomous thyroid adenoma]
Mueller-Gaertner HW.

veröffentlicht in: Acta Med Austriaca.; 17: 12-5., 1990

[Parametric representation of kidney function using 99mTc- mercaptoacetyltriglycine (MAG3)]
Szabo Z, Kutkuhn B, Georgescu G, Mecklenbeck W, Suatmadji A, Vosberg H.

veröffentlicht in: Nuklearmedizin.; 28: 73-83., 1989

[Long-term results following surgery orradioiodine treatment of solitary autonomous adenoma of the thyroid gland]
Muller-Gartner HW, Schneider C, Riechert B, Kayser D, Kremer B.

veröffentlicht in: Chirurg.; 60: 33-7., 1989

Increased deoxyribonucleic acid synthesis of autonomously functioning thyroid adenomas: independent of but further stimulable by thyrotropin
Muller-Gartner HW, Baisch H, Wiegel T, Kremer B, Schneider C.

veröffentlicht in: J Clin Endocrinol Metab.; 68: 39-45., 1989

Effects of renal artery reconstruction on kidney perfusion and tubular function measured by new radionuclide techniques
Torsello G, Szabo Z, Sandmann W, Vosberg H.

veröffentlicht in: J Cardiovasc Surg (Torino).; 29: 296-9. , 1988

[An experimental study of liver perfusion using non-diffusible radiotracers: differentiation of the arterial and portal venous components by deconvolution analysis of first-pass time-activity curves]
Szabo Z, Torsello G, Reifenrath C, Porschen R, Vosberg H.

veröffentlicht in: Nuklearmedizin. ; 27: 209-18., 1998

Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer
Muller-Gartner HW, Schneider C.

veröffentlicht in: Cancer.; 61: 976-81. , 1998

Autoradiographical evidence for increased thyrotropin binding to autonomously functioning thyroid gland tissue
Muller-Gartner HW, Jessel M, Schneider C, Bay V.

veröffentlicht in: J Endocrinol Invest.; 11: 183-91., 1998

[Radioimmunotherapy of solitary liver metastases using intratumor instillation of 131I-labeled monoclonal antibodies--initial results of a clinical study]
Muller-Gartner HW, Montz R, Klapdor R, Hirschmann M, Rehpenning W, Langkowski J.

veröffentlicht in: Nuklearmedizin.; 27: 258-65., 1998

3,5,3'-Triiodothyroacetic acid minimizes the pituitary thyrotrophin secretion in patients on levo-thyroxine therapy after ablative therapy for differentiated thyroid carcinoma
Mueller-Gaertner HW, Schneider C.

veröffentlicht in: Clin Endocrinol (Oxf).; 28: 345-51., 1988

The use of gamma functions in the calculation of organ perfusion functions for non-diffusible radioactive tracers
Hacklander T, Szabo Z, Vosberg H, Feinendegen LE.

veröffentlicht in: Phys Med Biol.; 33: 53-9. , 1998

Analysis of TSH receptors and microsomal antigen in different human thyroid tissue specimens
Furmaniak J, Davenport S, Nakajima Y, Kaiser U, Muller-Gartner HW, Buckmann FW, Pegg C, Rees Smith B.

veröffentlicht in: Clin Endocrinol (Oxf).; 28: 589-600. , 1988

Experimental studies on the renal transfer function for 131I-hippuran and 99mTc-DTPA
Szabo Z, Torsello G, Reifenrath C, Vosberg H.

veröffentlicht in: Contrib Nephrol.; 56: 71-6., 1987

[Morphology and prognosis of follicular thyroid cancer--a clinico- pathologic and DNA cytometric study of 95 tumors]
Schroder S, Baisch H, Rehpenning W, Muller-Gartner HW, Schulz-Bischof K, Sablotny B, Meiners I, Bocker W, Schreiber HW.

veröffentlicht in: Langenbecks Arch Chir. ; 370: 3-24., 1987

Inhomogenous TSH-binding in functional and proliferative thyroid disorders: evidence for different membrane characteristics, TSH- receptor capping and TSH-receptor presentation on the inner surface of the follicular epithelium
Muller-Gartner HW, Schneider C, Bay V, Tadt A, Jessel M.

veröffentlicht in: Acta Endocrinol Suppl.; 281: 193-8. , 1987

[After care in differentiated thyroid carcinoma]
Muller-Gartner HW.

veröffentlicht in: Dtsch Med Wochenschr.; 112: 326., 1987

Increased thyrotropin binding in hyperfunctioning thyroid nodules
Muller-Gartner HW, Schneider C, Bay V, Tadt A, Rehpenning W, de Heer K, Jessel M.

veröffentlicht in: Horm Metab Res. 19: 382-5. , 1987

[Percutaneous transthyroidal instillation treatment of parathyroid adenoma with ethanol in primary hyperparathyroidism]
Muller-Gartner HW, Beil FU, Schneider C, Ringe JD, Greten H.

veröffentlicht in: Dtsch Med Wochenschr.; 112: 1459-61., 1987

The utilization of Tc-99m-TBI as a myocardial perfusion agent in exercise studies: comparison with Tl-201 thallous chloride and examination of its biodistribution in humans
Sia ST, Holman BL, McKusick K, Rigo P, Gillis F, Sporn V, Perez-Balino N, Mitta A, Vosberg H, Szabo Z, et al.

veröffentlicht in: Eur J Nucl Med.; 12: 333-6., 1986

Morphological demonstration and quantification of TSH binding sites in neoplastic and non-neoplastic thyroid tissues. An autoradiographic study using 125I-labelled thyrotropin
Schroder S, Muller-Gartner HW, Schroiff R, Schmiegelow P, Niendorf A, Bocker W.

veröffentlicht in: Virchows Arch A Pathol Anat Histopathol.; 409: 555-70., 1986

Meta-iodobenzylguanidine scintigraphy in neuroblastoma--a comparison with conventional X-ray and ultrasound
Muller-Gartner HW, Erttmann R, Helmke K.

veröffentlicht in: Pediatr Hematol Oncol.; 3: 97-109. , 1986

[Gray-scale histogram analysis in thyroid sonography. Critique of visual evaluation of echogenicity]
Muller-Gartner HW.

veröffentlicht in: ROFO Fortschr Geb Rontgenstr Nuklearmed.; 145: 283-7. , 1986

Autoimmune-resistance in Graves' disease tissues indication of a structural and functional heterogenicity
Muller-Gartner HW, Schneider C, Schroder S.

veröffentlicht in: Acta Endocrinol (Copenh). ; 113: 233-41. , 1986

[Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values]
Muller-Gartner HW, Schneider C, Tempel MT.

veröffentlicht in: Nuklearmedizin.; 25: 194-200., 1986

Parameters of 99mTc-DTPA transfer function in renal artery stenosis
Szabo Z, Vosberg H, Torsello G, Sandmann W, Feinendegen LE.

veröffentlicht in: Cardiology.; 72: 46-8., 1985

Model identification and estimation of organ-function parameters using radioactive tracers and the impulse-response function
Szabo Z, Vosberg H, Sondhaus CA, Feinendegen LE.

veröffentlicht in: Eur J Nucl Med. 1985; 11: 265-74.

[Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma]
Muller-Gartner HW, Erttmann R, Helmke K.

veröffentlicht in: Nuklearmedizin.; 24: 222-6. , 1985


Nuclear medical determination of the left ventricular normalized velocity of contraction
Szabo Z, Ritzl F, Vosberg H.
The normalized velocity of contraction (vn) and its maximal value (vnmax) are related to the normalized flow acceleration within the ventricle, to the subendocardial fiber shortening rate, strain rate, and stress. This paper presents the method of the nuclear medical determination of vn and analyzes a typical volume-velocity-time curve. In 60 patients with different stages of coronary artery disease, global vnmax showed good correlation with the minimal ventricular transit time (y = 6.18-1.36 x, P less than 0.001) and global ejection fraction (y = -(2.5 + 356/(x - 104], P less than 0.001). The segmental vnmax showed a highly significant correlation with the regional ejection fraction (y = -(2.5 + 371/(x - 104], P less than 0.001). The mathematical relationships of vn with the mechanical properties of the ventricular wall are described in the appendix

veröffentlicht in: Eur J Nucl Med.; 9: 199-204., 1984

Measurement of mean retention times of 99mTc-labeled HSA- millimicrospheres in the liver--clinical results in patients with operated breast cancer
Szabo Z, Vosberg H, Segall M, Feinendegen LE.
Human serum albumin millimicrospheres labeled with 99mTc-pertechnetate were used for evaluation of their mean retention time in the hepatic RES cells. For this purpose the retention function was derived from the liver time-activity curves by deconvolution analysis. Measurements in 50 patients with operated breast cancer revealed significantly shorter retention times in patients with extrahepatic metastases in comparison with patients without evidence of metastases or recurrences. Discriminant analysis of the retention times combined with other investigated parameters such as relative organ size and extraction fraction of the liver and spleen, age, weight and height of the patient, proved the method to be diagnostically valuable. In the examined group of patients metastases could be demonstrated with a sensitivity of 100% and a specificity of 92%

veröffentlicht in: Nuklearmedizin.; 23: 171-6. , 1984


Age-related changes in peripheral thyroid parameters, it hypophyseal regulation and relation to fat metabolism
Hossdorf T, Gelis T, Lueg R, Vosberg H, Wagner H.
In 50 women and 57 men aged 20 to 80 years serum levels of T3, T4 and rT3 as well as TSH levels before and after intravenous application of TRH and serum triglycerid- and cholesterol-levels were determined. Regressions and multiple regressions were calculated with Broca-Index, and age. Serum-T3 are significantly lower in old age than in younger people. In men serum T4-levels remain unchanged in old age, in women a significant rise can be observed. With rising age TBK rises in men and falls in women. Women older than 50 years have significantly higher Serum-triglycerid- and cholesterrol-levels, Broca-Index being unchanged, than younger women. In men no remarkable change of these parameters could be detected. Calculating multiple regressions we found significant relations parameters could be detected. Calculating multiple regressions we found significant relations of T3-serum levels to either age and TBK or age and T4, as well as relations of rT3 serum levels to age and T4 levels in men and women. Only in men TSH-secretion following intravenous TRH application is related to age and serum-T3, or age and T4-serum levels or age and rT3-levels in serum. Broca-Index in men is related to age and T3-levels in serum. In both sexes serum-triglycerid-levels are significantly related to Broca-Index and rT3-levels or Broca-Index and T4-concentration in serum. Serum-cholesterol or triglyceride-levels correlate in women with age and T3-serum-concentrations. With increasing age in men and women hypothyreodism seems to be increasing

veröffentlicht in: Z Gerontol. 1980; 13: 6-17.

The circardian rhythm of the pituitary-thyroid regulatory cycle. Serum thyrotropin (TSH), thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3), and the thyroxine binding capacity (T3 test) in men in a diurnal profile
Veltrup FJ, Vosberg H, Wagner H.

veröffentlicht in: Med Welt.; 30: 1396-400. , 1979

Scintigraphic examinations of the lymph before endolymphatic radionuclide therapy of the malignant melanoma of the inferior extremity (author's transl)
Muller RP, Vosberg H, Peters PE, Hemmelskamp S.
A special 8-channel detector arrangement was used to determine atraumatically the mean blood flow velocities in the aorta and the large arteries of the lower extremities in man. Following intravenous injection of 99mTc-pertechnetate time-activity curves were recorded over defined measuring points over the arteries, from these the appearance times of the tracer determined, and the mean blood flow velocities calculated from the differences between appearance times (the minimal transit times) and the distances between measuring points. The simultaneous determination of the minimal transit times between the vena cava inferior and the root of the aorta, which correspond closely to the total cardiac transit times, permits recognition of cases in whom blood flow velocity is reduced as a result of cardiac disease

veröffentlicht in: Strahlentherapie.; 155: 243-7. , 1979

Radioimmunologic determination of serum triiodothyronine
Vosberg H.

veröffentlicht in: Ric Clin Lab. ; 7 Suppl 2: 27-39., 1977

Isotope angiographic measurement of blood flow velocity in the human aorta and major arteries. I. Methodology and physiological considerations
Schicha H, Becker V, Vosberg H, Vyska K, Feinendegen LE.
A special 8-channel detector arrangement was used to determine atraumatically the mean blood flow velocities in the aorta and the large arteries of the lower extremities in man. Following intravenous injection of 99mTc-pertechnetate time-activity curves were recorded over defined measuring points over the arteries, from these the appearance times of the tracer determined, and the mean blood flow velocities calculated from the differences between appearance times (the minimal transit times) and the distances between measuring points. The simultaneous determination of the minimal transit times between the vena cava inferior and the root of the aorta, which correspond closely to the total cardiac transit times, permits recognition of cases in whom blood flow velocity is reduced as a result of cardiac disease

veröffentlicht in: Nuklearmedizin.; 16: 214-7. , 1977

Extrathyroid-induced changes of serum triiodothyronine levels
Vosberg H, Backwinkel KP, Feyerabend H, Wagner H, Fiedler C.

veröffentlicht in: Verh Dtsch Ges Inn Med.; 82: 1882-5., 1976

Age-dependent changes of hypophysis-thyroid - regulation (author's transl)
Vosberg H, Wagner H, Bockel K, Hauss WH.
In health men and women different age total thyroxine, free thyroxine-binding-capacity, total triiodothyronine as well as TSH in serum before and after intravenous application of 500 mcg synthetic thyrothropine-releasing-hormone (TRH) were controlled. The investigations have shown: 1. With increasing age total thyroxine level in serum does not change. 2. With increasing age free thyroxine-binding-capacity in serum does not change. 3. With increasing age in men and women a significant decrease of total triiodothyronine in serum is to be measured. 4. Basal TSH serum levels do not change with increasing age. On the other hand in men and women with increasing age significant decreased TSH increments after TRH application were measured. The investigations have shown, that with increasing age the hypothalamus-hypophysial-thyroid-axis is shifting to a lower regulation level

veröffentlicht in: Aktuelle Gerontol.; 6: 279-84., 1976

Studies on the gravitation-dependent blood circulation distribution in the lung by means of double-nuclide perfusion scintigraphy
Meister R, Vosberg H, Herrmann D.

veröffentlicht in: Verh Dtsch Ges Inn Med.; 82: 1787-93., 1976

Value of renal scintigraphy in the diagnosis of kidney tumors
Lison AE, Vosberg H, Muller US.

veröffentlicht in: Med Welt. 1976; 27: 2266-8.

Determination of arterial blood flow velocity with external radioactivity measurement
Muller US, Vosberg H, Hemmelskamp S, Schicha H, Becker V, Vyska K, Feinendegen LE, Hauss WH.

veröffentlicht in: Verh Dtsch Ges Kreislaufforsch.; 41: 344-7. , 1975

Clinical significance of serum triiodothyronine determination
Vosberg H, Hrubesch M, Wagner H, Hauss WH.

veröffentlicht in: Med Welt.; 25: 1340-3. , 1974

Serum parathormone level and parathyroid gland scintigraphy. A contribution on the diagnosis of hyperparathyroidism
Hrubesch M, Wagner H, Vosberg H, Loew H, Hauss WH.

veröffentlicht in: Verh Dtsch Ges Inn Med.; 80: 1357-62., 1974

Proceedings: Scintigraphy of the lung in patients with scoliosis
Heine J, Meister R, Vosberg H, Bockler H.

veröffentlicht in: Z Orthop Ihre Grenzgeb.; 112: 829-32., 1974

Thyroid and adrenal gland function in rats with hereditary spontaneous hypertension
Wessels F, Wagner H, Vosberg H, Wenning N.

veröffentlicht in: Med Welt.; 24: 727-8., 1973

Significance of the Effective Thyroxine Ratio-ETR for the course evaluation of thyroid-specific therapy
Vosberg H, Hrubesch M, Wagner H, Hauss WH.

veröffentlicht in: Med Welt.; 24: 1535-6. , 1973

Pituitary-thyroid function in patients with chronic kidney failure under intermittent hemodialysis
Hrubesch M, Wagner H, Sturmer H, Bockel K, Vosberg H, Grote G, Wessels F, Loew H.

veröffentlicht in: Med Welt.; 24: 1532-4. , 1973

Further findings on the action of synthetic thyrotropin releasing hormone on the TSH serum level in various endocrine diseases
Wagner H, Bockel K, Grote G, Hrubesch M, Vosberg H, Junge-Hulsing G, Hauss WH.

veröffentlicht in: Med Welt.; 23: 1419-21. , 1972

Estimation of the free thyroxin level in serum by the free thyroxin factor controlled by the pituitary reaction effect
Vosberg H, Bockel K, Wagner H, Hauss WH.

veröffentlicht in: Med Welt.; 23: 1417-9. , 1972

"Effective thyroxine ratio", a simplified in-vitro procedure for estimating the free serum thyroxine level
Vosberg H, Wagner H, Bockel K, Hrubesch M.

veröffentlicht in: Med Welt.; 23: 1812-3. , 1972

Hyperthyreosis caused by a TSH-producing chromophobe hypophyseal adenoma
Hrubesch M, Bockel K, Vosberg H, Wagner H, Hauss WH.

veröffentlicht in: Verh Dtsch Ges Inn Med. 78: 1529-32. , 1972

Pituitary gland-thyroid gland regulationin mild struma: experiences with the thyreotropin releasing factor test
Hrubesch M, Grote G, Bockel K, Vosberg H, Wagner H.

veröffentlicht in: Med Welt.; 23: 1810-2. , 1972

H-TSH, thyroxine, HGH, insulin and glucose in the blood after administration of synthetic thyrotropin releasing hormone]
Wagner H, Hrubesch M, Vosberg H, Bockel K, Brisse B, Junge-Hulsing G, Hauss WH.

veröffentlicht in: [ Acta Endocrinol Suppl.; 152: 80. , 1971

Thyreotropin-releasing hormone and serum levels of H-TSH, HGH, thyroxine, insulin and glucose
Wagner H, Hruhesch M, Vosberg H, Bokel K, Brisse B, Junge-Hulsing G, Hauss WH.

veröffentlicht in: Horm Metab Res.; 3: 137-8., 1971

TSH-level in the sera of healthy subjects and patients with thyroid function disorders before andfollowing intravenous injection of synthetic thyrotropin-releasing hormone
Wagner H, Hrubesch M, Bockel K, Vosberg H, Junge-Hulsing G.

veröffentlicht in: Med Welt.; 47: 1883-4. , 1971

Thyroxine and TSH serum levels: parameter of the hypophysis-thyroid gland regulation
Vosberg H, Wagner H, Hrubesch M, Bockel K, Junge-Hulsing G.

veröffentlicht in: Verh Dtsch Ges Inn Med.; 77: 657-9. , 1971

Significance of serum TSH determination on the diagnosis of thyroid gland function disorders
Vosberg H, Hrubesch M, Bockel K, Wagner H.

veröffentlicht in: Med Welt.; 47: 1881-3. , 1971

Thyrotropin releasing hormone and serum levels of catecholamines as well as 11-hydroxycorticoids
Brisse B, Wagner H, Vosberg H, Hurbesch M, Bockel K, Hauss WH.

veröffentlicht in: Acta Endocrinol Suppl.; 152: 77. , 1971

MediathekInformation und Wissen
LageplanSo finden Sie uns